Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$6.16 - $8.08 $49,520 - $64,955
-8,039 Reduced 43.68%
10,365 $71,000
Q1 2024

May 15, 2024

SELL
$7.61 - $8.63 $29,785 - $33,777
-3,914 Reduced 17.54%
18,404 $141,000
Q4 2023

Feb 14, 2024

BUY
$5.7 - $9.14 $2,439 - $3,911
428 Added 1.96%
22,318 $195,000
Q3 2023

Nov 14, 2023

BUY
$6.35 - $8.16 $139,001 - $178,622
21,890 New
21,890 $159,000
Q2 2018

Aug 14, 2018

SELL
$5.39 - $8.96 $251,820 - $418,611
-46,720 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$10.87 - $13.9 $119,689 - $153,052
-11,011 Reduced 19.07%
46,720 $589,000
Q3 2017

Nov 14, 2017

BUY
$11.86 - $17.34 $684,689 - $1 Million
57,731
57,731 $686,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.03B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.